RT @philmw: Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing…
RT @philmw: Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing…
RT @philmw: Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing…
RT @philmw: Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing…
Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) shows efficacy against Osteosarcoma https://t.co/P9Fk5MBA0M
Preclinical testing of a novel niclosamide stearate prodrug therapeutic (NSPT) shows efficacy against osteosarcoma. https://t.co/lNjQdrEazH
Happy to share our work on a new formulation of niclosamide, a drug used to treat worms (!!!), now repurposed to kill a painful type of bone cancer that occurs mostly in kids! Canine clinical trial is ongoing. https://t.co/uvPk9C04j0